Home / Drug shortages / Docetaxel Injection

Docetaxel Injection — FDA Drug Shortage

To Be Discontinued — Ingenus Pharmaceuticals LLC

The FDA lists a drug shortage record for Docetaxel Injection (injection) from Ingenus Pharmaceuticals LLC with status To Be Discontinued. The shortage was first posted on 02/20/2026.

Shortage Details

Status
To Be Discontinued
Company
Ingenus Pharmaceuticals LLC
Package NDC
50742-431-08
Dosage Form
Injection
Presentation
Docetaxel, Injection, 10 mg/1 mL (NDC 50742-431-08)
Initial Posting
02/20/2026
Revised Date

FDA data resources